Edwards Lifesciences Corporation:企業のM&A・事業提携・投資動向

◆英語タイトル:Edwards Lifesciences Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2061
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Edwards Lifesciences Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Edwards Lifesciences Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Edwards Lifesciences Corporation since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Edwards Lifesciences Corporation’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Edwards Lifesciences Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Edwards Lifesciences Corporation’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Edwards Lifesciences Corporation and its subsidiaries since 2007.
- Information about key financial and legal advisors for Edwards Lifesciences Corporation’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Edwards Lifesciences Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Overview 7
Mergers and Acquisitions – Deal reports 8
CORPORATE VENTURING 25
Corporate Venturing – Overview 25
Corporate Venturing – Deal reports 26
PARTNERSHIP 37
Partnership – Deal reports 37
Divestments – Deal reports 53
APPENDIX 56
Contact Us 56
About MarketLine Financial Deals Database 56
Deal Definition and Methodology 58
About MarketLine 65

List of Tables
Table 1: Edwards Lifesciences Corporation M&A volume and value trend (2014-YTD2018)
Table 2: Edwards Lifesciences Corporation M&A activity by geography (2014-YTD2018)
Table 3: Edwards Lifesciences Corporation corporate venturing volume and value trend (2014-YTD2018)
Table 4: Edwards Lifesciences Corporation corporate venturing by geography (2014-YTD2018)

List of Figures
Figure 1: Edwards Lifesciences Corporation M&A volume and value trend (2014-YTD2018)
Figure 2: Edwards Lifesciences Corporation M&A activity by geography (2014-YTD2018)
Figure 3: Edwards Lifesciences Corporation corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Edwards Lifesciences Corporation corporate venturing by geography (2014-YTD2018)

★海外企業調査レポート[Edwards Lifesciences Corporation:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析
    Summary Chinese Academy of Sciences (CAS) is a research institute that provides advisory and appraisal services on issues arising from the national economy, social development, and science and technology progress. The institute offers services such as applied research, basic research, experimental d …
  • Xcel Energy Inc (XEL)-石油・ガス分野:企業M&A・提携分析
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Q BioMed Inc (QBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Q BioMed Inc (Q BioMed), formerly ISMO Tech Solutions Inc, is a biomedical acceleration and development company. The company offers Strontium Chloride SR89, a radiopharmaceutical agent for the treatment of pain associated with metastatic bone cancer. It develops Man-01, a pre-clinical lead c …
  • Frontage Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Frontage Laboratories Inc (Frontage), a subsidiary of Hangzhou Tigermed Consulting Co Ltd is a contract research organization that offers early phase drug development and other research services. The organization’s services include clinical research, drug metabolism and pharmacokinetic, CMC …
  • Bellvitge Biomedical Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary Bellvitge Biomedical Research Institute (IDIBELL) is a research centre focused on cellular medicine. It conducts clinical and basic research for developing treatments and techniques to improve health care. IDIBELL carries its research work in the fields of cancer and human molecular genetics …
  • ViaCyte Inc-製薬・医療分野:企業M&A・提携分析
    Summary ViaCyte Inc (ViaCyte), formerly Novocell, Inc. is a regenerative medicine company that focuses on the development of cell replacement therapies for the treatment of diabetes. The company’s pipeline product portfolio includes VC-01, which is being developed as a therapy for T1D patients who h …
  • Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Oil Search Ltd (Oil Search) is an independent upstream energy company. It explores for, develops and produces oil, natural gas and natural gas liquids (NGL). The company has majority of its oil and ga …
  • Adverum Biotechnologies Inc (ADVM):企業の財務・戦略的SWOT分析
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • S.A.G. Solar GmbH & Co KG:電力:M&Aディール及び事業提携情報
    Summary S.A.G. Solar GmbH & Co. KG. (S.A.G. Solar) a subsidiary of Shunfeng International Clean Energy Limited, is a manufacturer of photovoltaic systems. The company constructs, installs, operates and integrates solar power plants. It constructs rooftop systems, roof and facade-integrated systems, …
  • Penn National Gaming Inc:企業の戦略・SWOT・財務分析
    Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report Summary Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Calavo Growers, Inc. (CVGW):企業の財務・戦略的SWOT分析
    Calavo Growers, Inc. (CVGW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Teva Pharmaceutical Industries Ltd (TEVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, …
  • Pivotal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pivotal Therapeutics Inc (Pivotal Therapeutics) is a pharmaceutical company that develops and markets Omega-3 based therapies and therapeutic products for cardiovascular disorders. The company offers products such as VASCAZEN, a medical food formulated for the dietary management of an Omega- …
  • Dorel Industries Inc.:企業の戦略・SWOT・財務情報
    Dorel Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Dorel Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Metabolomic Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Metabolomic Diagnostics Ltd (Metabolomic Diagnostics) is an early stage medical diagnostic company that develops technology to provide predictive diagnosis of pre-eclampsia in early pregnancy. The company uses metabolic profiling for investigating the low molecular weight biochemicals existi …
  • AVANGRID, Inc.:企業の戦略・SWOT・財務分析
    AVANGRID, Inc. - Strategy, SWOT and Corporate Finance Report Summary AVANGRID, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Avantis Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avantis Medical Systems Inc (AMS) is a medical device company that provides visualization technology solutions. The company uses its technology platform and software analysis for the screening and early detection of cancer. It offers products such as single camera colonoscopy devices and thi …
  • Solvay Group:企業のM&A・事業提携・投資動向
    Solvay Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Solvay Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Banco Occidental de Descuento:企業の戦略・SWOT・財務情報
    Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report Summary Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Clean Harbors Inc (CLH):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Harbors Inc (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and onsite …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆